CGEM vs EXPD · $830.3M cap vs P/E 26, rev $10.60B
Cullinan Oncology LLC (CGEM) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
CGEM currently screens at market cap $830.3M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the CGEM and EXPD stock pages for the full models.
Not investment advice.